{"organizations": [], "uuid": "e77b6cf3d2b47681d7cd4929527fda21e881180d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-certain-arcturus-therapeutics-shar/brief-certain-arcturus-therapeutics-shareholders-expressed-support-for-former-ceo-joseph-paynes-leadership-idUSFWN1PW14Z", "country": "US", "domain_rank": 408, "title": "BRIEF-Certain Arcturus Therapeutics Shareholders Expressed Support For Former CEO Joseph Payne's Leadership", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-07T00:16:00.000+02:00", "replies_count": 0, "uuid": "e77b6cf3d2b47681d7cd4929527fda21e881180d"}, "author": "", "url": "https://www.reuters.com/article/brief-certain-arcturus-therapeutics-shar/brief-certain-arcturus-therapeutics-shareholders-expressed-support-for-former-ceo-joseph-paynes-leadership-idUSFWN1PW14Z", "ord_in_thread": 0, "title": "BRIEF-Certain Arcturus Therapeutics Shareholders Expressed Support For Former CEO Joseph Payne's Leadership", "locations": [], "entities": {"persons": [{"name": "joseph payne", "sentiment": "negative"}, {"name": "payne", "sentiment": "none"}], "locations": [], "organizations": [{"name": "sec", "sentiment": "none"}, {"name": "reuters) - arcturus therapeutics ltd", "sentiment": "none"}, {"name": "leadership reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 6 (Reuters) - Arcturus Therapeutics Ltd:\n* FORMER CEO JOSEPH PAYNE SAYS HE WAS APPROACHED BY CERTAIN ARCTURUS THERAPEUTICS SHAREHOLDERS, WHO EXPRESSED SUPPORT FOR HIS CONTINUED LEADERSHIP\n* FORMER CEO PAYNE SAYS INTENDS TO DISCUSS WITH SUPPORTING SHAREHOLDERS POTENTIAL CHANGES TO COMPOSITION OF ARCTURUS THERAPEUTICS BOARD, MANAGEMENT\n* FORMER CEO PAYNE SAYS INTENDS TO DISCUSS WITH SUPPORTING SHAREHOLDERS HIS IMMEDIATE REINSTATEMENT AS PRESIDENT AND CEO OF ARCTURUS THERAPEUTICS\n* FORMER CEO JOSEPH PAYNE REPORTS A 13.7 PERCENT STAKE IN ARCTURUS THERAPEUTICS AS OF NOVEMBER 16, 2017 - SEC FILING\n* FORMER CEO PAYNE - TO DISCUSS WITH SUPPORTING SHAREHOLDERS CHANGES INCLUDING ELECTION OF NEW DIRECTORS TO REPLACE ARCTURUS THERAPEUTICSâ€™ BOARD MEMBERS Source text for Eikon: Further company coverage:\n ", "external_links": [], "published": "2018-02-07T00:16:00.000+02:00", "crawled": "2018-02-07T00:33:43.000+02:00", "highlightTitle": ""}